A new study reports there appears to be no link between a high intake of dietary cholesterol and an increased risk of dementia, even in those who carried the APOE4 gene.
A new study sheds light into the link between lifestyle and the risk of developing dementia.
A new study reports carriers of APOE4 could have reduced risk of cognitive decline associated with parasitic infection.
Diet and lifestyle changes could lower the risk of developing Alzheimer's disease for those who are genetically predisposed, a new study suggests.
Researchers have implicated TOMM40, a gene adjacent to APOE on chromosome 19, in the development of Alzheimer's disease. TOMM40, researchers report, plays a significant role in the decline of verbal learning after the age of 60.
A new method of examining blood plasma allowed researchers to identify specific chemical bonds within the blood. The new technique allowed researchers to accurately distinguish between Alzheimer's disease and Lewy body dementia, thus reducing cases of misdiagnosis.
Researchers are testing a new vaccine and oral medication that could delay or prevent Alzheimer's disease from developing in those with a genetic predisposition.
UCSF researchers have developed a new genetic risk factor test that takes into account more than 24 genetic variants, each of which are associated with a small risk of Alzheimer's disease. The researchers say the test is a better method to help identify preclinical Alzheimer's than testing for ApoE4 alone.
Researchers are testing whether low doses of Rapamycin, a drug most commonly used as an immunosuppressant following an organ transplant, can help to prevent Alzheimer's disease.
According to a new study, people who have inflammation biomarkers in their blood during middle age are more likely to have increased brain shrinkage as they grow older. Researchers report the brain cell loss associated with inflammation was most prevalent in areas affected in Alzheimer's disease.